I decided to add the year to my title in the event that this thing goes on for another full year, and I have to do an update in May 2021. I pray fervently that such an eventuality will not come to pass, but it’s certainly possible. Having said that, your obedient servant […]
Articles
It’s hard to stay away from the coronavirus pandemic, even though Doc Gumshoe basically has no information that’s any different from what’s flooding into your inboxes or TV screens or, for those of us who are still members of the ancient fellowship of newspaper readers, the pages of our daily newspapers. But a few […]
Today I’m getting a lot of questions about the “Coronavirus Recovery Package” being pitched by Alexander Green — he’s selling Oxford Club subscriptions ($99) by promising a special report called “The Three Biggest Winners of the Coronavirus Recovery.” Green’s big-picture intro is pretty reasonable and rational, and similar to lots of other folks these days […]
I’ve gotten a few questions about the latest Technology Profits Confidential (currently $79/yr) tease from Ray Blanco, so although it’s a few weeks old now, and started circulating right in the heat of the first coronavirus downturn in mid-March, I thought I’d take a look today. It is still a current ad, I got it […]
It’s been a wild week. The mood was still pretty upbeat on Monday and Tuesday, a little anxiety but a lot of complacency (including mine)… I was in Toronto early this week, with plenty of hand washing and hand sanitizer but no real signs of panic or changes in lifestyle for most folks — the […]
This is the latest teaser pitch that a lot of folks have been asking about — and rightly so, I expect, because it’s designed to be extremely topical and get you revved up immediately. Here’s the intro to the ad that I’ve seen in some Angel Publishing newsletters: “We’re now in crisis mode over coronavirus […]
It’s been an unusually active month in the Real Money Portfolio — a couple big sells, several brand new positions, and quite a bit more churn than I usually have. Those transactions have mostly been fairly small, the largest position that I opened or closed was the sale of my sub-2% Facebook position, but that’s […]
What’s the bottom for the market selloff and are there any chinese stocks we could invest while the situation in US gets stabilized?It’s been a roller coaster ride so far this week. I’m a beginner in investing and waiting for the market selloff to reach the bottom. Given the situation that coronavirus just started spreading in US, anyone who can read the situation comment on what could be possible bottom or did we already reach it with […]
This is an update of a teaser solution from an older Friday File for everyone to read… I figure the Irregulars won’t be too upset, since the stock in question is up dramatically since this piece was published, but it’s still an interesting story — and a stock I own and would like to buy […]
Having just devoted an entire Doc Gumshoe piece to the notorious coronavirus (COVID 19), I’m going to make those coronavirus updates brief – it looks to me as though the news media is devoting a major part of its capacity to covering most aspects of this pandemic – and, yes, it now certainly looks like […]
It’s been a wild ride for the past couple weeks of coronavirus panic, and this week has been especially crazy (and still isn’t quite over)… though it’s encouraging that my Real Money Portfolio has been a little bit stronger than the market so far this year — partly because of brilliant stock selection, I’d like […]
Don’t look to Doc Gumshoe to keep you up to the minute on the spread of the Wuhan coronavirus. The figures I’m quoting below are as of mid-day today, February 18th. These will have changed by the time you see this piece, and they may be unreliable in the first place. But, […]
Please indulge Doc Gumshoe while he presents his musings on what’s going on in general in the health-care arena, and in particular, which new drugs are getting the FDA blessing and why, as well as which ones are getting the short straw. My impressions and conclusions are in some cases only loosely based on […]
Comments
Yes, there is the small possibility that a vaccine could make your reaction to the pathogen worse. That's one of the th...
I'm surprised you didn't bring up leronlimab. Mark this note....it will be the leading therapy for COVID-19 in short or...
Regarding C19 treatments, one you should keep your eye on is Leronlimab from Cytodyn, a small cap pharma. A BLA for HIV...
Agreed... My money is on CYDY for HIV and cancer, but C19 trials are eye opening.... This coming week will tell the tail...
In 1979 I began college for a pharmacy degree. My father in law was an emeritus professor at University of Michigan sch...
CEO of Co-Diagnostics $CODX was on Varney (FBN) on 3/5 mentioning the fact that recent relaxation of FDA restrictions no...
Headline from 3/1: Vaxart, Inc. (NasdaqGS: VXRT), a clinical-stage biotechnology company developing oral recombinant vac...
TOMZ recent headline: https://finance.yahoo.com/news/steramist-declared-official-decontamination-technology-143010170.ht...
Just some ideas: "CODX", maker of diagnostic kits for Covid-19 could go vertical once approved by FDA/CDC. The stock ha...
Great and informative article from a medical prospective. What stocks do u all think will rally, even if temporarily, du...